Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5459)
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,319
Price
$5.40
Total Value
$28.72K
Shares Held After
532,091
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
311
Price
$540.17
Total Value
$167.99K
Shares Held After
8,480
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
1,414
Price
$539.25
Total Value
$762.49K
Shares Held After
8,791
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
275
Price
$537.62
Total Value
$147.85K
Shares Held After
10,205
% of Holdings
2.6%
IMPACT BIOMEDICAL INC. (IBO)
Macko Todd D — Chief Financial Officer
Shares
1,600
Price
$0.60
Total Value
$961.28
Shares Held After
198,122
% of Holdings
0.8%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
3,575
Price
$60.08
Total Value
$214.77K
Shares Held After
1,220,004
% of Holdings
0.3%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
2,511
Price
$106.46
Total Value
$267.32K
Shares Held After
41,967
% of Holdings
5.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
2,000
Price
$85.00
Total Value
$170.00K
Shares Held After
179,371
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
160
Price
$17.53
Total Value
$2.80K
Shares Held After
5,129,340
% of Holdings
0.0%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
174,485
Price
$16.95
Total Value
$2.96M
Shares Held After
5,129,500
% of Holdings
3.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
40,000
Price
$35.10
Total Value
$1.40M
Shares Held After
25,000
% of Holdings
61.5%
Tyra Biosciences, Inc. (TYRA)
KAPLAN GILLA — Director
Shares
14,295
Price
$36.97
Total Value
$528.51K
Shares Held After
28,231
% of Holdings
33.6%
Phreesia, Inc. (PHR)
Gandhi Balaji — Chief Financial Officer
Shares
3,829
Price
$11.26
Total Value
$43.13K
Shares Held After
146,740
% of Holdings
2.5%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
26,198
Price
$50.07
Total Value
$1.31M
Shares Held After
2,918,326
% of Holdings
0.9%
Legend Biotech Corp (LEGN)
Huang Ying — Director
Shares
9,936
Price
$8.77
Total Value
$87.14K
Shares Held After
247,438
% of Holdings
3.9%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
125,000
Price
$1.40
Total Value
$175.00K
Shares Held After
8,868,276
% of Holdings
1.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
552
Price
$56.86
Total Value
$31.39K
Shares Held After
59,240
% of Holdings
0.9%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
4,916
Price
$56.00
Total Value
$275.32K
Shares Held After
59,792
% of Holdings
7.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,572
Price
$55.28
Total Value
$86.90K
Shares Held After
64,708
% of Holdings
2.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
833
Price
$21.47
Total Value
$17.88K
Shares Held After
25,852
% of Holdings
3.1%
ACADIA PHARMACEUTICALS INC (ACAD)
Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Shares
3,844
Price
$21.47
Total Value
$82.53K
Shares Held After
11,280
% of Holdings
25.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research & Dev
Shares
3,435
Price
$21.47
Total Value
$73.75K
Shares Held After
3,280
% of Holdings
51.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Owen Adams Catherine — Director
Shares
11,641
Price
$21.47
Total Value
$249.93K
Shares Held After
14,803
% of Holdings
44.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
4,177
Price
$21.47
Total Value
$89.68K
Shares Held After
57,299
% of Holdings
6.8%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
400
Price
$97.21
Total Value
$38.88K
Shares Held After
54,400
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
11,036
Price
$96.43
Total Value
$1.06M
Shares Held After
54,800
% of Holdings
16.8%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
21,086
Price
$95.49
Total Value
$2.01M
Shares Held After
65,836
% of Holdings
24.3%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
3,128
Price
$94.16
Total Value
$294.52K
Shares Held After
86,922
% of Holdings
3.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,800
Price
$93.22
Total Value
$167.80K
Shares Held After
90,050
% of Holdings
2.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$1.22
Total Value
$366.00
Shares Held After
274,766
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.27
Total Value
$271.99K
Shares Held After
473,230
% of Holdings
3.9%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
5,500
Price
$18.95
Total Value
$104.23K
Shares Held After
55,286
% of Holdings
9.0%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
10,702
Price
$18.47
Total Value
$197.67K
Shares Held After
271,079
% of Holdings
3.8%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
24,431
Price
$18.47
Total Value
$451.24K
Shares Held After
752,454
% of Holdings
3.1%
Definium Therapeutics, Inc. (DFTX)
Karlin Daniel — Chief Medical Officer
Shares
8,018
Price
$18.47
Total Value
$148.09K
Shares Held After
413,317
% of Holdings
1.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
7,098
Price
$5.50
Total Value
$39.04K
Shares Held After
537,410
% of Holdings
1.3%
GENELUX Corp (GNLX)
Smalling Ralph — Head of Regulatory
Shares
240
Price
$2.51
Total Value
$602.40
Shares Held After
68,073
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
13,700
Price
$100.16
Total Value
$1.37M
Shares Held After
85,533
% of Holdings
13.8%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
10,115
Price
$29.99
Total Value
$303.35K
Shares Held After
286,876
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$548.52
Total Value
$197.47K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$547.78
Total Value
$251.43K
Shares Held After
40,873
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
373
Price
$546.59
Total Value
$203.88K
Shares Held After
41,332
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
911
Price
$545.72
Total Value
$497.15K
Shares Held After
41,705
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,544
Price
$544.65
Total Value
$840.94K
Shares Held After
42,616
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,721
Price
$543.68
Total Value
$935.67K
Shares Held After
44,160
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,833
Price
$542.66
Total Value
$994.69K
Shares Held After
45,881
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,699
Price
$541.75
Total Value
$920.43K
Shares Held After
47,714
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.51
Total Value
$237.83K
Shares Held After
49,413
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$538.73
Total Value
$21.55K
Shares Held After
49,853
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$536.97
Total Value
$64.44K
Shares Held After
49,893
% of Holdings
0.2%
Showing 201–250 of 5459 transactions (page 5 of 110)